J. Nick

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “566 Repurposing antimalarials drugs for the treatment of nontuberculous mycobacterium infections”.

566 Repurposing antimalarials drugs for the treatment of nontuberculous mycobacterium infections

Journal of Cystic Fibrosis(2022)10.1016/s1569-1993(22)01256-5

N/A

0DataRank · unranked

1 citations

D. Verma, W. Li, C. Avanzi, C. Wiersma, J. WILLIAMS +15 more

530 Airway volatile organic compounds can achieve culture-independent identification of Nontuberculous mycobacteria in people with cystic fibrosis

Journal of Cystic Fibrosis(2022)10.1016/s1569-1993(22)01220-6

N/A

0DataRank · unranked

0 citations

A. Gao, L. Kang, J. Nick, K. Poch, J. Hill +1 more

520 Molecular evidence of Mycobacterium abscessus in nontuberculous mycobacterium patient cohorts classified by sputum culture

Journal of Cystic Fibrosis(2022)10.1016/s1569-1993(22)01210-3

N/A

0DataRank · unranked

0 citations

N. Rysavy, K. Callahan, F. Jia, K. Poch, S. Caceres +4 more